At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 12 enrolled
Drug / intervention
Memantinedrug
Likely dose
Memantine 30mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Memantine Treatment of Kleptomania: An Open-Label Study
In Brief
A Phase 2 clinical trial evaluating Memantine for Kleptomania. Completed, enrolled 12 participants across 1 site.
Detailed Summary
The goal of the proposed study is to evaluate the efficacy and safety of memantine in kleptomania.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKleptomania
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2009
First PostedApr 2009
Primary CompletionMay 2012
Study CompletionJun 2012
TodayJul 2026
First PostedApr 14, 2009
Enrollment StartMar 1, 2009
Primary CompletionMay 1, 2012
Study CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 17.2 years ago
Interventions
Memantinedrug
10-30mg, daily for 8 weeks